153 related articles for article (PubMed ID: 9177865)
1. Systemic administration of an anabolic dose of PGE2 in young rats increases the osteogenic capacity of bone marrow.
Weinreb M; Suponitzky I; Keila S
Bone; 1997 Jun; 20(6):521-6. PubMed ID: 9177865
[TBL] [Abstract][Full Text] [Related]
2. Systemic administration of an anabolic dose of prostaglandin E2 induces early-response genes in rat bones.
Weinreb M; Rutledge SJ; Rodan GA
Bone; 1997 Apr; 20(4):347-53. PubMed ID: 9108355
[TBL] [Abstract][Full Text] [Related]
3. Systemic prostaglandin E2 increases cancellous bone formation and mass in aging rats and stimulates their bone marrow osteogenic capacity in vivo and in vitro.
Keila S; Kelner A; Weinreb M
J Endocrinol; 2001 Jan; 168(1):131-9. PubMed ID: 11139777
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of systemic prostaglandin E2 on bone mass in rat long bones and calvariae.
Suponitzky I; Weinreb M
J Endocrinol; 1998 Jan; 156(1):51-7. PubMed ID: 9496233
[TBL] [Abstract][Full Text] [Related]
5. A selective EP4 receptor antagonist abrogates the stimulation of osteoblast recruitment from bone marrow stromal cells by prostaglandin E2 in vivo and in vitro.
Shamir D; Keila S; Weinreb M
Bone; 2004 Jan; 34(1):157-62. PubMed ID: 14751573
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow cells are targets for the anabolic actions of prostaglandin E2 on bone: induction of a transition from nonadherent to adherent osteoblast precursors.
Scutt A; Bertram P
J Bone Miner Res; 1995 Mar; 10(3):474-87. PubMed ID: 7785470
[TBL] [Abstract][Full Text] [Related]
7. Anabolic effect of prostaglandin E2 in bone is not dependent on pituitary hormones in rats.
Chen MM; Yeh JK; Aloia JF
Calcif Tissue Int; 1998 Sep; 63(3):236-42. PubMed ID: 9701628
[TBL] [Abstract][Full Text] [Related]
8. The anabolic effect of PGE2 in rat bone marrow cultures is mediated via the EP4 receptor subtype.
Weinreb M; Grosskopf A; Shir N
Am J Physiol; 1999 Feb; 276(2):E376-83. PubMed ID: 9950799
[TBL] [Abstract][Full Text] [Related]
9. Transient effects of subcutaneously administered prostaglandin E2 on cancellous and cortical bone in young adult dogs.
Li XJ; Jee WS; Li YL; Patterson-Buckendahl P
Bone; 1990; 11(5):353-64. PubMed ID: 2252812
[TBL] [Abstract][Full Text] [Related]
10. Anabolic effect of prostaglandin E2 on cortical bone of aged male rats comes mainly from modeling-dependent bone gain.
Yao W; Jee WS; Zhou H; Lu J; Cui L; Setterberg R; Liang T; Ma Y
Bone; 1999 Dec; 25(6):697-702. PubMed ID: 10593415
[TBL] [Abstract][Full Text] [Related]
11. The role of glucocorticoids and prostaglandin E2 in the recruitment of bone marrow mesenchymal cells to the osteoblastic lineage: positive and negative effects.
Scutt A; Bertram P; Bräutigam M
Calcif Tissue Int; 1996 Sep; 59(3):154-62. PubMed ID: 8694891
[TBL] [Abstract][Full Text] [Related]
12. Anabolic responses of an adult cancellous bone site to prostaglandin E2 in the rat.
Ito H; Ke HZ; Jee WS; Sakou T
Bone Miner; 1993 Jun; 21(3):219-36. PubMed ID: 8400921
[TBL] [Abstract][Full Text] [Related]
13. Long-term anabolic effects of prostaglandin-E2 on tibial diaphyseal bone in male rats.
Jee WS; Ke HZ; Li XJ
Bone Miner; 1991 Oct; 15(1):33-55. PubMed ID: 1747567
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia.
Ke HZ; Shen VW; Qi H; Crawford DT; Wu DD; Liang XG; Chidsey-Frink KL; Pirie CM; Simmons HA; Thompson DD
Bone; 1998 Sep; 23(3):249-55. PubMed ID: 9737347
[TBL] [Abstract][Full Text] [Related]
15. Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow.
Nishida S; Yamaguchi A; Tanizawa T; Endo N; Mashiba T; Uchiyama Y; Suda T; Yoshiki S; Takahashi HE
Bone; 1994; 15(6):717-23. PubMed ID: 7873302
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2-mediated anabolic effect of a novel inhibitor of phosphodiesterase 4, XT-611, in the in vitro bone marrow culture.
Miyamoto K; Suzuki H; Yamamoto S; Saitoh Y; Ochiai E; Moritani S; Yokogawa K; Waki Y; Kasugai S; Sawanishi H; Yamagami H
J Bone Miner Res; 2003 Aug; 18(8):1471-7. PubMed ID: 12929936
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 (PGE2) increases the number of rat bone marrow osteogenic stromal cells (BMSC) via binding the EP4 receptor, activating sphingosine kinase and inhibiting caspase activity.
Weinreb M; Shamir D; Machwate M; Rodan GA; Harada S; Keila S
Prostaglandins Leukot Essent Fatty Acids; 2006 Aug; 75(2):81-90. PubMed ID: 16890416
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cyclo-oxigenase-2 activity does not abolish the anabolic effect of prostaglandin E2 in vivo or in vitro.
Weinreb M; Kelner A; Keila S
J Endocrinol; 2002 Jul; 174(1):127-35. PubMed ID: 12098671
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow from mechanically unloaded rat bones expresses reduced osteogenic capacity in vitro.
Keila S; Pitaru S; Grosskopf A; Weinreb M
J Bone Miner Res; 1994 Mar; 9(3):321-7. PubMed ID: 8191925
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 administration prevents bone loss induced by orchidectomy in rats.
Li M; Jee WS; Ke HZ; Tang LY; Ma YF; Liang XG; Setterberg RB
J Bone Miner Res; 1995 Jan; 10(1):66-73. PubMed ID: 7747632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
